Integrated care model for pulmonary infection in stroke patients with tracheotomy

Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy

NA · Shenzhen Second People's Hospital · NCT05505487

This study is testing a new care plan for stroke patients with tracheotomy to see if it helps prevent lung infections and makes things easier for their caregivers.

Quick facts

PhaseNA
Study typeInterventional
Enrollment80 (estimated)
Ages18 Years to 100 Years
SexAll
SponsorShenzhen Second People's Hospital (other)
Locations1 site (Shenzhen, Guangdong)
Trial IDNCT05505487 on ClinicalTrials.gov

What this trial studies

This study aims to construct and evaluate an integrated care model specifically designed for non-acute stroke patients with tracheotomy who are at risk of pulmonary infections. It involves a retrospective analysis of patient data, clinical observations, and expert consultations to develop a systematic approach to care. The effectiveness of this model will be assessed by comparing clinical outcomes, such as infection severity and caregiver burden, before and after its implementation. The study will utilize convenience sampling to select participants from the Department of Rehabilitation Medicine at Shenzhen Second People's Hospital.

Who should consider this trial

Good fit: Ideal candidates for this study are non-acute stroke patients aged 18 and older who have undergone tracheotomy and are off mechanical ventilation.

Not a fit: Patients with unstable vital signs or those requiring ICU treatment, as well as those with malignant tumors or other infectious diseases, may not benefit from this study.

Why it matters

Potential benefit: If successful, this integrated care model could significantly reduce the severity of pulmonary infections in stroke patients with tracheotomy, improving their overall health outcomes.

How similar studies have performed: While this approach is based on existing literature, the specific integrated care model being evaluated is novel and has not been extensively tested in this patient population.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Non-acute stroke patients diagnosed by MRI or CT who meet the diagnostic criteria of the "Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases";
* Those who meet the diagnostic criteria for pulmonary infection;
* Age ≥18 years old;
* Tracheotomy patients who have been off the ventilator or do not need mechanical ventilation;
* Patients who can cooperate with the research and sign the informed consent.

Exclusion Criteria:

* Patients whose vital signs are unstable and may be transferred to ICU for treatment in the future;
* Patients with malignant tumors or other infectious diseases.

Where this trial is running

Shenzhen, Guangdong

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Stroke, Pulmonary Infection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.